phosphoglucomutase 1 deficiency

mwooten / Pixabay

IND Application for Experimental PGM1 Deficiency Drug Accepted

Post author:James Moore
Post published:January 24, 2019
Post category:Rare Disease

According to a press release from the biopharmaceutical company Cerecor, Inc., the US Food and Drug Administration (FDA) recently agreed to accept the company's Investigational New Drug (IND) application for its…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More